TRANSLATE

Welcome to Our Parkinson's Place


I copy news articles pertaining to research, news and information for Parkinson's disease, Dementia, the Brain, Depression and Parkinson's with Dystonia. I also post about Fundraising for Parkinson's disease and events. I try to be up-to-date as possible. I have Parkinson's
diseases as well and thought it would be nice to have a place where
updated news is in one place. That is why I began this blog.
I am not responsible for it's contents, I am just a copier of information searched on the computer. Please understand the copies are just that, copies and at times, I am unable to enlarge the wording or keep it uniformed as I wish. This is for you to read and to always keep an open mind.
Please discuss this with your doctor, should you have any questions, or concerns. Never do anything without talking to your doctor. I do not make any money from this website. I volunteer my time to help all of us to be informed. Please No advertisers, and No Information about Herbal treatments. This is a free site for all.
Thank you.


Monday, April 10, 2017

How this North Shields firm is working towards revolutionising Parkinson’s Disease detection

April 10, 2017


Could this pen be the future of Parkinson’s diagnosis? Photo courtesy of Manus Neurodynamica


North Shields medical innovation company Manus Neurodynamica has won a contract to further develop technology capable of detecting Parkinson’s Disease in a GP setting.

Manus has developed diagnostic sensor technology built into a pen, reportedly capable of differentiating a Parkinson’s patient from a patient with another neuromotor condition.
Landing a SBRI Healthcare Development Contract, the company can now develop its ManusNeuro pen further. Should the pen prove successful it could save the healthcare industry both time and money, by removing the process of referring patients for a scan.
The sensory pen, which the company says uses limb and hand motion to diagnose patients quickly and noninvasively, would also ensure that only those patients who need to see a specialist are referred by the GP.
Manus, which has patented the diagnostic system, will now work with clinicians and NHS Health economists to further develop the pen.
Additional trials are on-going with six NHS Trusts in the North East of England under the supervision of Professor Richard Walker, Consultant Physician/Honorary Professor of Ageing & International Health, Newcastle University.
Professor Walker said: “The ManusNeuro pen may help identify patients where the symptoms are not typical or have not developed. In situations where there is some doubt, we often refer patients for a scan, but these cost £1,000 a time, so if the pen allows us to be more sure about the diagnosis it should mean we will need to refer fewer people for expensive scans.“
Dr Rutger Zietsma, Managing Director of Manus Neurodynamica, added: “Using our pen in the 9,800 GP practices in England will reduce costs by ending the unnecessary referrals of patients to specialist centres.
“Our 21st century diagnostic can differentiate a Parkinson’s patient from a patient with another neuromotor condition and ensure that only those patients who need to see a specialist are referred by the GP to an already overstretched service. We are excited to be working with the NHS to achieve this goal.“
https://bdaily.co.uk/technology/10-04-2017/how-this-north-shields-firm-is-working-towards-revolutionising-parkinsons-disease-detection/

No comments:

Post a Comment